3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
21
Meningioma
6
Gastro-enteropancreatic neuroendocrine tumor
6
Pheochromocytoma
3
Paraganglioma
3
Prostatic Neoplasms
2
Neuroblastoma
2
Medulloblastoma
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Carcinoma, Merkel Cell
2
Adenoma, Islet Cell
2
Somatostatin Receptor-positive Neuroendocrine Tumor
1
Sarcoma, Synovial
1
Recurrence
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Hypertension
1
Extensive Stage Small Cell Lung Cancer
1
Esthesioneuroblastoma, Olfactory
1
Disease Progression
1
Digestive System Neuroendocrine Tumor G1
1
Diffuse Intrinsic Pontine Glioma
1
Central Nervous System Neoplasms
1
Carcinoma, Neuroendocrine
1
Carcinoma
1
Interventions
Fluorouracil
8
Oxaliplatin
7
Surveys and Questionnaires
6
Leucovorin
6
Blood Specimen Collection
6
Specimen Handling
5
Gemcitabine
5
Cetuximab
5
Capecitabine
5
Bevacizumab
5
fludarabine
4
aldesleukin
4
Standard of Care
4
Cyclophosphamide
4
Remote Patient Monitoring
3
Radiosurgery
3
Pafolacianine
3
Nivolumab
3
Irinotecan
3
Endoscopic Mucosal Resection
3
Cisplatin
3
130-nm albumin-bound paclitaxel
3
encorafenib
2
Tomography, X-Ray Computed
2
Sunitinib
2
Referral and Consultation
2
Radiotherapy
2
Practice Guidelines as Topic
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
lutetium Lu 177 dotatate
×
1 year
×
Clear all
No trials found.